Anti-cyclic citrullinated peptide and rheumatoid factor in patients with chronic hepatitis B and hepatitis B carriers

DALKILIÇ H. E., ÖKSÜZ M. F., tufan a. n., özbek a., nizamoğlu a., DÖLARSLAN M. E., ...Daha Fazla

European Journal of Rheumatology, cilt.2, sa.2, ss.62-65, 2015 (ESCI) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 2 Sayı: 2
  • Basım Tarihi: 2015
  • Doi Numarası: 10.5152/eurjrheum.2015.0101
  • Dergi Adı: European Journal of Rheumatology
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.62-65
  • Anahtar Kelimeler: Hepatitis B, anti-cyclic citrullinated peptide, rheumatoid factor, rheumatoid arthritis, C VIRUS-INFECTION, CCP ANTIBODIES, ARTHRITIS, CRYOGLOBULINEMIA, AUTOANTIBODIES, CLASSIFICATION, CRITERIA, ABSENCE, DISEASE, SERA
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: Rheumatoid factor (RF) positivity that may occur in a number of patients with hepatitis B (HBV) infection poses challenges in terms of differential diagnosis with rheumatoid arthritis (RA). On the other hand, antibodies to cyclic citrullinated peptide (anti-CCP) may prove to be an important marker for differential diagnosis of the two conditions. This study aimed to assess anti-CCP and RF positivity among patients with hepatitis B and rheumatoid arthritis.